Selected research
Industry Research
West Nile Virus Infections Medicine Industry Research Report 2026
Market perspective
The global West Nile Virus Infections Medicine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for West Nile Virus Infections Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for West Nile Virus Infections Medicine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for West Nile Virus Infections Medicine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of West Nile Virus Infections Medicine include Theravectys SA, Plex Pharmaceuticals Inc, Nanotherapeutics Inc, Kineta Inc, Hemispherx Biopharma Inc, Fab'entech SA and CEL-SCI Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global West Nile Virus Infections Medicine market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
West Nile Virus Infections Medicine Market by Company
Theravectys SA
Plex Pharmaceuticals Inc
Nanotherapeutics Inc
Kineta Inc
Hemispherx Biopharma Inc
Fab'entech SA
CEL-SCI Corp
West Nile Virus Infections Medicine Segment by Type
AGS-v
BG-323
CEL-1000
FDX-000
Others
West Nile Virus Infections Medicine Segment by Application
Hospital
Clinic
Others
West Nile Virus Infections Medicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global West Nile Virus Infections Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of West Nile Virus Infections Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of West Nile Virus Infections Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of West Nile Virus Infections Medicine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of West Nile Virus Infections Medicine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of West Nile Virus Infections Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- AGS-v
- BG-323
- CEL-1000
- FDX-000
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- Theravectys SA
- Plex Pharmaceuticals Inc
- Nanotherapeutics Inc
- Kineta Inc
- Hemispherx Biopharma Inc
- Fab'entech SA
- CEL-SCI Corp
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global West Nile Virus Infections Medicine Market Size (2021-2032)
- 2.2.2 Global West Nile Virus Infections Medicine Sales (2021-2032)
- 2.2.3 Global West Nile Virus Infections Medicine Market Average Price (2021-2032)
- 2.3 West Nile Virus Infections Medicine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 AGS-v
- 2.3.3 BG-323
- 2.3.4 CEL-1000
- 2.3.5 FDX-000
- 2.3.6 Others
- 2.4 West Nile Virus Infections Medicine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global West Nile Virus Infections Medicine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global West Nile Virus Infections Medicine Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global West Nile Virus Infections Medicine Revenue of Manufacturers (2021-2026)
- 3.4 Global West Nile Virus Infections Medicine Average Price by Manufacturers (2021-2026)
- 3.5 Global West Nile Virus Infections Medicine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of West Nile Virus Infections Medicine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of West Nile Virus Infections Medicine, Product Type & Application
- 3.8 Global Manufacturers of West Nile Virus Infections Medicine, Established Date
- 3.9 Global West Nile Virus Infections Medicine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Theravectys SA
- 4.1.1 Theravectys SA Company Information
- 4.1.2 Theravectys SA Business Overview
- 4.1.3 Theravectys SA West Nile Virus Infections Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Theravectys SA West Nile Virus Infections Medicine Product Portfolio
- 4.1.5 Theravectys SA Recent Developments
- 4.2 Plex Pharmaceuticals Inc
- 4.2.1 Plex Pharmaceuticals Inc Company Information
- 4.2.2 Plex Pharmaceuticals Inc Business Overview
- 4.2.3 Plex Pharmaceuticals Inc West Nile Virus Infections Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Plex Pharmaceuticals Inc West Nile Virus Infections Medicine Product Portfolio
- 4.2.5 Plex Pharmaceuticals Inc Recent Developments
- 4.3 Nanotherapeutics Inc
- 4.3.1 Nanotherapeutics Inc Company Information
- 4.3.2 Nanotherapeutics Inc Business Overview
- 4.3.3 Nanotherapeutics Inc West Nile Virus Infections Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Nanotherapeutics Inc West Nile Virus Infections Medicine Product Portfolio
- 4.3.5 Nanotherapeutics Inc Recent Developments
- 4.4 Kineta Inc
- 4.4.1 Kineta Inc Company Information
- 4.4.2 Kineta Inc Business Overview
- 4.4.3 Kineta Inc West Nile Virus Infections Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Kineta Inc West Nile Virus Infections Medicine Product Portfolio
- 4.4.5 Kineta Inc Recent Developments
- 4.5 Hemispherx Biopharma Inc
- 4.5.1 Hemispherx Biopharma Inc Company Information
- 4.5.2 Hemispherx Biopharma Inc Business Overview
- 4.5.3 Hemispherx Biopharma Inc West Nile Virus Infections Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hemispherx Biopharma Inc West Nile Virus Infections Medicine Product Portfolio
- 4.5.5 Hemispherx Biopharma Inc Recent Developments
- 4.6 Fab'entech SA
- 4.6.1 Fab'entech SA Company Information
- 4.6.2 Fab'entech SA Business Overview
- 4.6.3 Fab'entech SA West Nile Virus Infections Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Fab'entech SA West Nile Virus Infections Medicine Product Portfolio
- 4.6.5 Fab'entech SA Recent Developments
- 4.7 CEL-SCI Corp
- 4.7.1 CEL-SCI Corp Company Information
- 4.7.2 CEL-SCI Corp Business Overview
- 4.7.3 CEL-SCI Corp West Nile Virus Infections Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 CEL-SCI Corp West Nile Virus Infections Medicine Product Portfolio
- 4.7.5 CEL-SCI Corp Recent Developments
5 Global West Nile Virus Infections Medicine Market Scenario by Region
- 5.1 Global West Nile Virus Infections Medicine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global West Nile Virus Infections Medicine Sales by Region: 2021-2032
- 5.2.1 Global West Nile Virus Infections Medicine Sales by Region: 2021-2026
- 5.2.2 Global West Nile Virus Infections Medicine Sales by Region: 2027-2032
- 5.3 Global West Nile Virus Infections Medicine Revenue by Region: 2021-2032
- 5.3.1 Global West Nile Virus Infections Medicine Revenue by Region: 2021-2026
- 5.3.2 Global West Nile Virus Infections Medicine Revenue by Region: 2027-2032
- 5.4 North America West Nile Virus Infections Medicine Market Facts & Figures by Country
- 5.4.1 North America West Nile Virus Infections Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America West Nile Virus Infections Medicine Sales by Country (2021-2032)
- 5.4.3 North America West Nile Virus Infections Medicine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe West Nile Virus Infections Medicine Market Facts & Figures by Country
- 5.5.1 Europe West Nile Virus Infections Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe West Nile Virus Infections Medicine Sales by Country (2021-2032)
- 5.5.3 Europe West Nile Virus Infections Medicine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific West Nile Virus Infections Medicine Market Facts & Figures by Country
- 5.6.1 Asia Pacific West Nile Virus Infections Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific West Nile Virus Infections Medicine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific West Nile Virus Infections Medicine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America West Nile Virus Infections Medicine Market Facts & Figures by Country
- 5.7.1 South America West Nile Virus Infections Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America West Nile Virus Infections Medicine Sales by Country (2021-2032)
- 5.7.3 South America West Nile Virus Infections Medicine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa West Nile Virus Infections Medicine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa West Nile Virus Infections Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa West Nile Virus Infections Medicine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa West Nile Virus Infections Medicine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global West Nile Virus Infections Medicine Sales by Type (2021-2032)
- 6.1.1 Global West Nile Virus Infections Medicine Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global West Nile Virus Infections Medicine Sales Market Share by Type (2021-2032)
- 6.2 Global West Nile Virus Infections Medicine Revenue by Type (2021-2032)
- 6.2.1 Global West Nile Virus Infections Medicine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global West Nile Virus Infections Medicine Revenue Market Share by Type (2021-2032)
- 6.3 Global West Nile Virus Infections Medicine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global West Nile Virus Infections Medicine Sales by Application (2021-2032)
- 7.1.1 Global West Nile Virus Infections Medicine Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global West Nile Virus Infections Medicine Sales Market Share by Application (2021-2032)
- 7.2 Global West Nile Virus Infections Medicine Revenue by Application (2021-2032)
- 7.2.1 Global West Nile Virus Infections Medicine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global West Nile Virus Infections Medicine Revenue Market Share by Application (2021-2032)
- 7.3 Global West Nile Virus Infections Medicine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 West Nile Virus Infections Medicine Value Chain Analysis
- 8.1.1 West Nile Virus Infections Medicine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 West Nile Virus Infections Medicine Production Mode & Process
- 8.2 West Nile Virus Infections Medicine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 West Nile Virus Infections Medicine Distributors
- 8.2.3 West Nile Virus Infections Medicine Customers
9 Global West Nile Virus Infections Medicine Analyzing Market Dynamics
- 9.1 West Nile Virus Infections Medicine Industry Trends
- 9.2 West Nile Virus Infections Medicine Industry Drivers
- 9.3 West Nile Virus Infections Medicine Industry Opportunities and Challenges
- 9.4 West Nile Virus Infections Medicine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst